HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Z Chen Selected Research

Ovarian Neoplasms (Ovarian Cancer)

5/2021[Development and functional validation of a nano-delivery system of miR-16/polypeptide targeting ovarian cancer cells].
1/2006Functional duality of merlin: a conundrum of proteome complexity.
1/2005Improving Reliability of Response Prediction to Platinum-Based Therapy by AdaBoost and Multiple Classifiers.
1/2005Integration of clinical information and gene expression profiles for prediction of chemo-response for ovarian cancer.
1/2001Activation of caspase protease during apoptosis in ovarian cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Z Chen Research Topics

Disease

132Neoplasms (Cancer)
01/2024 - 01/2000
50Infections
06/2023 - 01/2000
34Neoplasm Metastasis (Metastasis)
01/2022 - 01/2000
29Inflammation (Inflammations)
03/2024 - 04/2000
20Carcinogenesis
04/2020 - 05/2000
16Breast Neoplasms (Breast Cancer)
04/2020 - 10/2000
15Leukemia
01/2020 - 02/2000
15Acute Promyelocytic Leukemia
01/2011 - 02/2000
14Hepatocellular Carcinoma (Hepatoma)
01/2023 - 09/2000
13Squamous Cell Carcinoma of Head and Neck
07/2023 - 05/2000
13Carcinoma (Carcinomatosis)
02/2013 - 01/2000
12Prostatic Neoplasms (Prostate Cancer)
12/2018 - 12/2001
11Atopic Dermatitis (Atopic Eczema)
02/2022 - 01/2018
10Hemorrhage
11/2022 - 03/2000
10Stomach Neoplasms (Stomach Cancer)
07/2020 - 05/2000
9Pain (Aches)
03/2024 - 01/2003
9Wounds and Injuries (Trauma)
09/2023 - 08/2000
9Hypoxia (Hypoxemia)
01/2023 - 07/2001
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 06/2000
9Ischemia
12/2020 - 10/2000
8Human Influenza (Influenza)
12/2023 - 06/2000
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 10/2000
8Diabetes Mellitus
12/2019 - 06/2009
7Osteoporosis
08/2023 - 10/2003
7Necrosis
03/2021 - 11/2000
7Reperfusion Injury
12/2020 - 08/2000
7Lung Neoplasms (Lung Cancer)
06/2017 - 02/2000
7Cardiovascular Diseases (Cardiovascular Disease)
05/2014 - 03/2001
6Fibrosis (Cirrhosis)
10/2023 - 08/2014
6Pneumonia (Pneumonitis)
11/2022 - 07/2001
6Colorectal Neoplasms (Colorectal Cancer)
06/2020 - 12/2006
5Hypertension (High Blood Pressure)
03/2024 - 04/2007
5COVID-19
02/2024 - 01/2020
5Glioblastoma (Glioblastoma Multiforme)
01/2024 - 08/2000
5Obesity
01/2024 - 05/2014
5Ovarian Neoplasms (Ovarian Cancer)
05/2021 - 01/2001
5Heart Failure
05/2021 - 10/2003
5Hypersensitivity (Allergy)
01/2021 - 03/2000
5Burns
05/2020 - 08/2000
5Atherosclerosis
08/2019 - 07/2000
5Liver Neoplasms (Liver Cancer)
11/2018 - 03/2001
5Thrombosis (Thrombus)
10/2018 - 07/2000
5Type 2 Diabetes Mellitus (MODY)
10/2017 - 07/2009
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2017 - 01/2016
4Insulin Resistance
01/2024 - 03/2001

Drug/Important Bio-Agent (IBA)

70Proteins (Proteins, Gene)FDA Link
10/2023 - 03/2000
28CytokinesIBA
03/2024 - 01/2000
27Messenger RNA (mRNA)IBA
01/2017 - 01/2000
24DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2000
18Biomarkers (Surrogate Marker)IBA
11/2023 - 09/2000
14VaccinesIBA
01/2021 - 01/2000
14AntigensIBA
01/2018 - 01/2000
14Tretinoin (Retinoic Acid)FDA LinkGeneric
02/2004 - 02/2000
11dupilumabIBA
02/2022 - 01/2018
10NF-kappa B (NF-kB)IBA
03/2024 - 11/2000
10Interleukin-6 (Interleukin 6)IBA
11/2018 - 01/2000
10Arsenic Trioxide (Trisenox)FDA Link
01/2011 - 02/2000
9EnzymesIBA
09/2017 - 06/2001
9Transcription Factors (Transcription Factor)IBA
01/2017 - 11/2000
9Complementary DNA (cDNA)IBA
04/2008 - 08/2000
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020 - 02/2001
8Epidermal Growth Factor (EGF)IBA
04/2020 - 03/2000
8AntibodiesIBA
07/2017 - 08/2000
8Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016 - 07/2000
8ChemokinesIBA
10/2015 - 07/2000
7RNA (Ribonucleic Acid)IBA
02/2024 - 05/2000
7Cisplatin (Platino)FDA LinkGeneric
05/2021 - 03/2000
7MicroRNAs (MicroRNA)IBA
12/2020 - 01/2014
7CateninsIBA
10/2020 - 01/2011
7Monoclonal AntibodiesIBA
01/2020 - 01/2000
7Glucose (Dextrose)FDA LinkGeneric
06/2018 - 11/2001
6Cadherins (E-Cadherin)IBA
08/2023 - 09/2009
6Indicators and Reagents (Reagents)IBA
01/2022 - 03/2012
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 11/2016
6Peptides (Polypeptides)IBA
05/2021 - 08/2001
6ErbB Receptors (EGF Receptor)IBA
07/2020 - 09/2003
6Insulin (Novolin)FDA Link
07/2020 - 06/2000
6Interleukin-10 (Interleukin 10)IBA
01/2020 - 08/2001
6LipidsIBA
01/2018 - 03/2001
6Small Interfering RNA (siRNA)IBA
01/2017 - 11/2006
6DNA VaccinesIBA
01/2008 - 06/2000
5Circular RNAIBA
08/2023 - 01/2020
5Interleukin-13IBA
01/2020 - 01/2018
5InterleukinsIBA
01/2020 - 08/2001
5Immunoglobulin E (IgE)IBA
01/2019 - 01/2000
5Tyrosine Kinase InhibitorsIBA
03/2018 - 01/2016
5IntegrinsIBA
11/2017 - 04/2000
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2017 - 11/2000
5Transforming Growth Factor beta (TGF-beta)IBA
01/2017 - 11/2000
5Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2016 - 11/2000
5Phosphotransferases (Kinase)IBA
01/2016 - 08/2000
5ApolipoproteinsIBA
08/2015 - 07/2000
5Peptide Hydrolases (Proteases)FDA Link
07/2015 - 01/2000
5CaspasesIBA
08/2009 - 01/2000
5promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
01/2007 - 01/2001
4Hemoglobins (Hemoglobin)IBA
03/2024 - 01/2017

Therapy/Procedure

68Therapeutics
09/2023 - 03/2000
22Drug Therapy (Chemotherapy)
12/2023 - 01/2000
15Radiotherapy
01/2024 - 02/2000
6Liver Transplantation
05/2012 - 12/2007